9,935
Total Claims
$1.4M
Drug Cost
966
Beneficiaries
$1,407
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-77%
Opioid rate vs peers
0.6% vs 2.6% avg
+32%
Cost per patient vs peers
$1,407 vs $1,068 avg
+70%
Brand preference vs peers
15.3% vs 9.0% avg
Opioid Prescribing
0.6%
Opioid Rate
59
Opioid Claims
$892
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
85% generic
Brand: 1,505 claims · $1.1M
Generic: 8,324 claims · $206K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 126 | $160K |
| Liraglutide | 46 | $99K |
| Fluticasone/Umeclidin/Vilanter | 97 | $91K |
| Semaglutide | 78 | $89K |
| Empagliflozin | 80 | $83K |
| Tirzepatide | 49 | $72K |
| Dulaglutide | 62 | $68K |
| Empagliflozin/Metformin Hcl | 52 | $56K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $30K |
| Rivaroxaban | 26 | $30K |
| Budesonide/Formoterol Fumarate | 57 | $27K |
| Tiotropium Bromide | 34 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $20K |
| Liraglutide | 16 | $19K |
| Tiotropium Bromide | 29 | $18K |
Prescribing Profile
Patient Profile
73
Avg Age
70%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data